Hefei Hengxin Life Science and Technology Co 301501.SZ · CNY
Materials · Shenzhen · 🇨🇳 China
23.64
-0.96%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥1.84bn
FY2021FY2025
Net income
CN¥223.8m
FY2021FY2025
Free cash flow
−CN¥188.4m
FY2021FY2025
Shareholders' equity
CN¥2.11bn
FY2021FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.84bn | CN¥1.59bn | CN¥1.43bn | CN¥1.09bn | CN¥718.9m |
| Research and development | CN¥52.8m | CN¥53.4m | CN¥44.2m | CN¥35.9m | CN¥32.2m |
| Operating income | CN¥293.4m | CN¥266.1m | CN¥269.9m | CN¥195.6m | CN¥95.8m |
| Net income | CN¥223.8m | CN¥219.9m | CN¥213.9m | CN¥162.8m | CN¥80.3m |
| Diluted earnings per share | 1.51 | 1.98 | 1.45 | 1.10 | 0.54 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Total assets | CN¥2.85bn | CN¥1.98bn | CN¥1.57bn | CN¥1.21bn | CN¥727.9m |
| Total liabilities | CN¥677.7m | CN¥869.4m | CN¥690.5m | CN¥565.7m | CN¥246.1m |
| Debt | CN¥67.5m | CN¥94.1m | CN¥110.5m | CN¥74.4m | — |
| Shareholders' equity | CN¥2.11bn | CN¥1.05bn | CN¥821.5m | CN¥608.8m | — |
| Shares outstanding | 148m | 111m | 148m | 148m | 148m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Cash from operations | CN¥339.6m | CN¥373.8m | CN¥219.5m | CN¥292.6m | CN¥143.9m |
| Capital spending | −CN¥528.0m | −CN¥452.6m | −CN¥330.3m | −CN¥290.1m | −CN¥134.1m |
| Free cash flow | −CN¥188.4m | −CN¥78.7m | −CN¥110.9m | CN¥2.6m | CN¥9.8m |
| Dividends paid | −CN¥58.8m | −CN¥11.4m | −CN¥7.6m | −CN¥19.5m | −CN¥9.7m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | Jun 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥484.9m | CN¥450.5m | CN¥460.7m | CN¥451.8m | CN¥419.1m | CN¥435.7m | CN¥455.4m | CN¥395.5m |
| Operating income | CN¥38.4m | CN¥41.8m | CN¥57.0m | CN¥63.1m | CN¥58.3m | −CN¥892.3m | CN¥455.4m | CN¥69.9m |
| Net income | CN¥29.8m | CN¥32.3m | CN¥39.0m | CN¥43.5m | CN¥81.9m | CN¥57.9m | CN¥60.7m | CN¥59.2m |
| Diluted earnings per share | 0.20 | 0.22 | 0.26 | 0.29 | 0.55 | 0.52 | 0.55 | 0.53 |
| Capital spending | −CN¥147.0m | −CN¥98.0m | −CN¥123.0m | −CN¥113.0m | −CN¥98.0m | — | — | −CN¥81.0m |
| Total assets | CN¥2.81bn | CN¥2.80bn | CN¥2.85bn | CN¥2.73bn | CN¥2.90bn | CN¥1.98bn | CN¥1.86bn | CN¥1.74bn |
| Debt | CN¥102.5m | CN¥72.5m | CN¥67.5m | CN¥72.5m | CN¥94.1m | CN¥94.1m | — | CN¥110.8m |
| Shareholders' equity | CN¥2.09bn | CN¥2.12bn | CN¥2.11bn | CN¥2.00bn | CN¥2.03bn | CN¥1.05bn | CN¥993.1m | CN¥926.5m |
Financial ratios
Data as of 12 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Operating margin | 16.1% | 17.6% | 18.9% | 18.4% | 100.0% |
| Net margin | 12.1% | 13.8% | 15.0% | 15.0% | 11.2% |
| Return on equity | 10.6% | 21.0% | 26.0% | 26.7% | — |
| Return on assets | 7.8% | 11.1% | 13.6% | 13.4% | 11.0% |
| Free cash flow yield | 21.5% | 27.4% | — | — | — |
| Revenue growth | 15.7% | 11.9% | 30.9% | 51.4% | — |
| Earnings growth | 1.8% | 2.8% | 31.4% | 102.8% | — |
| Current ratio | 2.12x | 1.03x | 1.32x | 1.40x | 1.88x |
| Debt to equity | 0.03x | 0.09x | 0.13x | 0.12x | — |
| Equity ratio | 73.8% | 52.7% | 52.2% | 50.2% | — |
| Interest coverage | 39.86x | 14.01x | 25.29x | 22.77x | 274.65x |
| R&D as a share of sales | 2.9% | 3.3% | 3.1% | 3.3% | 4.5% |
| Buybacks as a share of market value | -33.3% | — | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 19.4% | — | — |
| Operating income | 14.5% | — | — |
| Net income | 11.2% | — | — |
Valuation history
At each fiscal year end
| FY2025 | |
|---|---|
| Price to earnings | 28.9 |
| Price to sales | 3.5 |
Dividends and splits
Per share, in the currency the company pays
Paid for 1 years. Last went ex-dividend on 6 Jun 2025.
| FY2025 | |
|---|---|
| Paid in the year | 0.345 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.